Skip to main content

Articles

Page 6 of 68

  1. The criteria for metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) remain controversial. This research aimed to identify a potential biomarker to differentiate the subtypes of obesity.

    Authors: Baowen Yu, Moran Hu, Wanzi Jiang, Yizhe Ma, Jingya Ye, Qinyi Wu, Wen Guo, Yan Sun, Min Zhou, Yiwen Xu, Zhoulu Wu, Yiwen Wang, Sin Man Lam, Guanghou Shui, Jingyu Gu, John Zhong Li…
    Citation: Lipids in Health and Disease 2023 22:166
  2. Non-high-density lipoprotein-cholesterol (non-HDL-C) has been identified as a potential biomarker for metabolic syndrome (MetS). However, its predictive capability for MetS varies among different ethnic groups...

    Authors: Fatemeh Vazirian, Susan Darroudi, Hamid Reza Rahimi, MohamadReza Latifi, Behrouz Shakeri, Samaneh Abolbashari, Amir Hooshang Mohammadpour, Habibollah Esmaily, Mohsen Mouhebati, Sara Samadi and Majid Ghayour Mobarhan
    Citation: Lipids in Health and Disease 2023 22:165
  3. Urinary 3-indoxyl sulfate levels as well as fecal short chain fatty acid (SCFA) concentrations are surrogate markers for gut microbiota diversity. Patients with inflammatory bowel diseases (IBDs) and patients ...

    Authors: Hauke Christian Tews, Tanja Elger, Stefan Gunawan, Tanja Fererberger, Stefanie Sommersberger, Johanna Loibl, Muriel Huss, Gerhard Liebisch, Martina Müller, Arne Kandulski and Christa Buechler
    Citation: Lipids in Health and Disease 2023 22:164
  4. Controlling cholesterol levels is one of the primary goals of preventing atherosclerotic plaque progression in patients undergoing coronary artery bypass graft (CABG) surgery. This study aimed to investigate t...

    Authors: Aryan Ayati, Kasra Akbari, Akbar Shafiee, Arezou Zoroufian, Arash Jalali, Sahar Samimi, Mina Pashang, Kaveh Hosseini, Jamshid Bagheri and Farzad Masoudkabir
    Citation: Lipids in Health and Disease 2023 22:163
  5. The triglyceride-glucose index (TyG index) is an indicator of insulin resistance that has been studied recently. The relationship between insulin resistance and the risk of hypertension has been documented pre...

    Authors: Anna D. Argoty-Pantoja, Rafael Velázquez-Cruz, Joacim Meneses-León, Jorge Salmerón and Berenice Rivera-Paredez
    Citation: Lipids in Health and Disease 2023 22:162
  6. Specific ceramides have been identified as risk markers for cardiovascular disease (CVD) years before onset of disease. Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide has bee...

    Authors: Asger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, Tommi Suvitaival, Jin Xu, Emilie Hein Zobel, Bernt Johan von Scholten, Rasmus Sejersten Ripa, Andreas Kjaer, Tine Willum Hansen, Tina Vilsbøll, Henrik Vestergaard, Peter Rossing and Cristina Legido-Quigley
    Citation: Lipids in Health and Disease 2023 22:160
  7. Currently, there is limited and controversial clinical research on the correlation between sleep-disordered breathing (SDB) and dyslipidemia. This discrepancy in findings may be because studies that primarily ...

    Authors: Tong Feng, Guangliang Shan, Huijing He, Guo Pei, Jiaoying Tan, Bing Lu and Qiong Ou
    Citation: Lipids in Health and Disease 2023 22:159
  8. Cholesterol metabolism is a risk factor for cardiovascular disease, and recent studies have shown that cholesterol metabolism poses a residual risk of cardiovascular disease even when conventional lipid risk f...

    Authors: Yuxuan Wu, Qinfei Wei, Husheng Li, Han Yang, Yuying Wu, Yiming Yu, Qiansi Chen, Baochang He and Fa Chen
    Citation: Lipids in Health and Disease 2023 22:158
  9. Lipid metabolism disorders are considerably involved in the pathology of atherosclerosis; nevertheless, the fundamental mechanism is still largely unclear. This research sought to examine the function of lipop...

    Authors: Tingting Wang, Zheng Cheng, Ran Zhao, Jin Cheng, He Ren, Pengke Zhang, Pengyun Liu, Qimeng Hao, Qian Zhang, Xiaolei Yu, Dongdong Sun and Dongwei Zhang
    Citation: Lipids in Health and Disease 2023 22:156
  10. Hepatitis C has been associated with the development of hepatic steatosis, which increases the risk of liver cancer. The microsomal triglyceride transporter protein (MTTP), is a lipid transport protein that me...

    Authors: Xiaoxia Wang, Yu Cao, Jia Guo, Dezhao Li, Haitao Zhang, Qingkun Song and Jun Lu
    Citation: Lipids in Health and Disease 2023 22:154
  11. Adipose tissue, which is mainly composed of adipocytes, is a crucial component of the tumor microenvironment, particularly in breast cancer. Adipocytes surround breast cancer cells and may participate in cell‒...

    Authors: Jinna Wu, Jia Li, Huiya Xu, Ni Qiu, Xiaojia Huang and Hongsheng Li
    Citation: Lipids in Health and Disease 2023 22:153
  12. It is well established that the consumption of trans-fatty acids (TFAs) can increase the incidence of total mortality, cardiovascular disease, cancer, and diabetes. However, there are still no demographic stud...

    Authors: Yuancheng Zhou, Chengcheng Wei, Xincheng Gao, Yi Sun and Xiaomin Han
    Citation: Lipids in Health and Disease 2023 22:152
  13. Although generic drugs have been approved with the assurance of interchangeable applications with original drugs, some physicians, and patients still view their efficacy and interchangeability negatively. Usin...

    Authors: Yu-Cheol Lim, Eui-Kyung Lee and Mi-Hai Park
    Citation: Lipids in Health and Disease 2023 22:151
  14. Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease. Metabolism-related genes significantly influence the onset and progression of the disease. Hence, it is necessary to screen metabolism...

    Authors: Hua Jiang, Yang Hu, Zhibo Zhang, Xujia Chen and Jianpeng Gao
    Citation: Lipids in Health and Disease 2023 22:150
  15. This study aimed to investigate the association between the Dietary Inflammatory Index (DII) and dyslipidemia, as well as to evaluate the mortality risk associated with DII in participants with dyslipidemia.

    Authors: Xiaozhe Chen, Chunlei Hou, Lei Yao, Jianhua Li, Mingtai Gui, Mingzhu Wang, Xunjie Zhou, Bo Lu and Deyu Fu
    Citation: Lipids in Health and Disease 2023 22:149
  16. Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disease with a global prevalence, and modulation of ANGPTL8 expression has emerged as a promising predictor of NAFLD susceptibility. This r...

    Authors: Samira Saghafi, Elham Chamani, Fatemeh Salmani, Reza Fadaei, Efat Shafiei, Nariman Moradi and Tahmine Tavakoli
    Citation: Lipids in Health and Disease 2023 22:147
  17. Lipid metabolism affects type 2 immunity; however, the association between plasma lipids and eosinophilic inflammation in humans is uncertain. This study analysed the relationship between plasma lipids and per...

    Authors: Yu Gao, Xiaocheng Wang, Lan Gao, Xin Li and Weihong Bai
    Citation: Lipids in Health and Disease 2023 22:146
  18. The absence of distinct symptoms in the majority of individuals with metabolic dysfunction-associated fatty liver disease (MAFLD) poses challenges in identifying those at high risk, so we need simple, efficien...

    Authors: Haoxuan Zou, Xiaopu Ma, Fan Zhang and Yan Xie
    Citation: Lipids in Health and Disease 2023 22:145
  19. Lipoprotein (a) [Lp(a)] is an apoB100-containing lipoprotein with high levels being positively associated with atherosclerotic cardiovascular disease. Lp(a) levels are genetically determined. However, previous...

    Authors: Anastasiya Matveyenko, Heather Seid, Kyungyeon Kim, Rajasekhar Ramakrishnan, Tiffany Thomas, Nelsa Matienzo and Gissette Reyes-Soffer
    Citation: Lipids in Health and Disease 2023 22:144
  20. Recent studies have shown that triglyceride glucose-body mass index (TyG-BMI) is associated with the risk of ischemic stroke and coronary artery disease. However, little attention has been given to the associa...

    Authors: Cuixia Zhan, Yuan Peng, Hongjian Ye, Xiangwen Diao, Chunyan Yi, Qunying Guo, Wei Chen and Xiao Yang
    Citation: Lipids in Health and Disease 2023 22:143
  21. Recent studies have shown that loss-of-function mutations in hepatic asialoglycoprotein receptor 1 (ASGR1) are associated with low levels of circulating cholesterol and a reduced risk of coronary artery diseas...

    Authors: Qin Luo, Jingfei Chen, Yingjie Su, Panyun Wu, Jiangang Wang, Zhenfei Fang and Fei Luo
    Citation: Lipids in Health and Disease 2023 22:142
  22. The prognostic value of lipoprotein (Lp) (a) in patients who have suffered from coronary artery disease (CAD) has not been fully studied, and the results are inconsistent. This study was conducted to evaluate ...

    Authors: Lin Zhao, Lin Sun, ZengLei Zhang, KunQi Yang, ZuoZhi Li, Man Wang, Yan Zeng, XianLiang Zhou and WeiXian Yang
    Citation: Lipids in Health and Disease 2023 22:141
  23. Hyperlipidemia is closely associated with dietary patterns and inflammation. However, the relationship between hyperlipidemia and the inflammatory potential of diets remains unexplored. The research was conduc...

    Authors: Yu Han, Xijuan Jiang, Yabin Qin, Yile Zhao, Guying Zhang and Chao Liu
    Citation: Lipids in Health and Disease 2023 22:140

    The Correction to this article has been published in Lipids in Health and Disease 2023 22:161

  24. To explore the impact of visceral obesity (VO) measured by preoperative abdominal computed tomography (CT) on postoperative infectious complications for colorectal cancer (CRC) patients and establish a predict...

    Authors: Wenshan Zhai, Yi Yang, Keyao Zhang, Lei Sun, Meng Luo, Xue Han, Min Wang, Zhiping Wang and Fang Gao
    Citation: Lipids in Health and Disease 2023 22:139
  25. Oxylipins, the oxidative metabolites of polyunsaturated fatty acids (PUFAs), serve as key mediators of oxidative stress, inflammatory responses, and vasoactive reactions in vivo. Our previous work has establis...

    Authors: Tong Liu, Inci Dogan, Michael Rothe, Evgenij Potapov, Felix Schoenrath, Maik Gollasch, Friedrich C. Luft and Benjamin Gollasch
    Citation: Lipids in Health and Disease 2023 22:138
  26. Nonalcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disorder worldwide. According to several previous studies, the treatment of patients with NAFLD using medicinal and food-homologous substan...

    Authors: Qian Zhang, Yatian Jia, Yuexing Zhang, Yan Wang, Xinru Li, Xiaoying Tian and Shifan Han
    Citation: Lipids in Health and Disease 2023 22:137
  27. The purpose of this study was to comprehensively evaluate the lipid profiles in patients with juvenile idiopathic arthritis (JIA).

    Authors: Wen-Jia Zhao, Jiang-Hong Deng and Cai-Feng Li
    Citation: Lipids in Health and Disease 2023 22:136

    The Correction to this article has been published in Lipids in Health and Disease 2023 22:148

  28. ​Develop and validate a nomogram prediction model for hypertension-diabetes comorbidities based on chronic disease management in the community.

    Authors: Yan Wu, Wei Tan, Yifeng Liu, Yongli Li, Jiali Zou, Jinsong Zhang and Wenjuan Huang
    Citation: Lipids in Health and Disease 2023 22:135
  29. Anlotinib has demonstrated encouraging clinical outcomes in the treatment of lung cancer, soft tissue sarcoma and thyroid carcinoma. Several clinical studies have shown a relationship between anlotinib treatme...

    Authors: Zhongling Zhu, Shan Xu, Jing Ren, Teng Jiang, Cai Zhang and Zhao Yan
    Citation: Lipids in Health and Disease 2023 22:134
  30. Desaturase enzymes play a key role in several pathways including biosynthesis of poly- and mono- unsaturated fatty acids (PUFAs, MUFA). In preterm infants, desaturase enzyme activity (DA) may be a rate-limitin...

    Authors: Hanis Hidayu Kasim, Laurentya Olga, Stuart Snowden, Eliza Cropp, Albert Koulman and Kathryn Beardsall
    Citation: Lipids in Health and Disease 2023 22:133
  31. Insulin resistance is a well-established contributor to inflammation; however, the specific association between the triglyceride glucose (TyG) index, a biomarker reflecting insulin resistance, and arthritis re...

    Authors: Yuxin Yan, Liyu Zhou, Rui La, Ming Jiang, Dinghua Jiang, Lixin Huang, Wu Xu and Qian Wu
    Citation: Lipids in Health and Disease 2023 22:132

    The Correction to this article has been published in Lipids in Health and Disease 2024 23:60

  32. The platelet/high-density lipoprotein cholesterol ratio (PHR) is a novel inflammatory and hypercoagulability marker that represents the severity of metabolic syndrome. Liver metabolic syndrome is manifested by...

    Authors: Chun-feng Lu, Xiao-min Cang, Wang-shu Liu, Li-hua Wang, Hai-yan Huang, Sheng-mei Sang, Xue-qin Wang, Xing-xing Fang and Feng Xu
    Citation: Lipids in Health and Disease 2023 22:130
  33. Epidemiological evidence on the relationship between exposure to volatile organic compounds (VOCs), both single and mixed, and serum lipid levels is limited, and their relationship remains unclear. Our study a...

    Authors: Wen-Yu Chen, Yan-Peng Fu, Hui Tu, Wen Zhong and Liang Zhou
    Citation: Lipids in Health and Disease 2023 22:129
  34. Lipoprotein lipase (LPL) is the rate-limiting enzyme for triglyceride hydrolysis. Homozygous or compound heterozygous LPL variants cause autosomal recessive familial chylomicronemia syndrome (FCS), whereas simple...

    Authors: Guofu Zhang, Yuepeng Hu, Qi Yang, Na Pu, Gang Li, Jingzhu Zhang, Zhihui Tong, Emmanuelle Masson, David N. Cooper, Jian-Min Chen and Weiqin Li
    Citation: Lipids in Health and Disease 2023 22:128
  35. This study aimed to investigate the role of cholesterol metabolism-related genes in nonfunctioning pituitary neuroendocrine tumors (NF-PitNETs) invading the cavernous sinus and analyze the differences in immun...

    Authors: Tianshun Feng, Pengwei Hou, Shuwen Mu, Yi Fang, Xinxiong Li, Ziqi Li, Di Wang, Li Chen, Lingling Lu, Kunzhe Lin and Shousen Wang
    Citation: Lipids in Health and Disease 2023 22:127
  36. Hearing loss is a prevalent health concern, and dietary factors, such as fatty acid intake, may play a role in its development. The current study aimed to investigate the association between the intake of diet...

    Authors: Xiaojin Zhang, Qin Luo, Zhicheng Huang and Xin Xiang
    Citation: Lipids in Health and Disease 2023 22:126
  37. Accumulating evidence indicated that apolipoprotein B (apoB) was the principal lipid determinant of coronary artery disease (CAD). Nevertheless, the connection between apoB and angiographic progression of CAD ...

    Authors: Xing Shui, Zheqi Wen, Ruimin Dong, Zefeng Chen, Leile Tang, Wenyu Tang, Zhen Wu and Lin Chen
    Citation: Lipids in Health and Disease 2023 22:125
  38. Nonalcoholic fatty liver disease (NAFLD) is now the major contributor to chronic liver disease. Disorders of lipid metabolism are a major element in the emergence of NAFLD. This research intended to explore li...

    Authors: Jifeng Liu, Yiming Li, Jingyuan Ma, Xing Wan, Mingjian Zhao, Yunshu Zhang and Dong Shang
    Citation: Lipids in Health and Disease 2023 22:124
  39. The global incidence of nonalcoholic fatty liver disease (NAFLD) is rapidly escalating, positioning it as a principal public health challenge with significant implications for population well-being. Given its ...

    Authors: Rui Meng, Hui Wang, Zhikang Si, Xuelin Wang, Zekun Zhao, Haipeng Lu, Yizhan Zheng, Jiaqi Chen, Huan Wang, Jiaqi Hu, Ling Xue, Xiaoming Li, Jian Sun and Jianhui Wu
    Citation: Lipids in Health and Disease 2023 22:123
  40. Nonpuerperal mastitis (NPM) is a disease that presents with redness, swelling, heat, and pain during nonlactation and can often be confused with breast cancer. The etiology of NPM remains elusive; however, eme...

    Authors: Xiaoxiao Chen, Shijun Shao, Xueqing Wu, Jiamei Feng, Wenchao Qu, Qingqian Gao, Jiaye Sun and Hua Wan
    Citation: Lipids in Health and Disease 2023 22:122
  41. Patients with multi-vessel coronary artery disease (MV-CAD) have poorer clinical outcomes than those with single-vessel coronary artery disease (SV-CAD). Solid evidence underlines that high-density lipoprotein...

    Authors: Jiaqi Chen, Kangxiang Wu, Wanchun Cao, Jianan Shao and Mingyuan Huang
    Citation: Lipids in Health and Disease 2023 22:121
  42. Obesity is often accompanied by metabolic disorder and insulin resistance, resulting in type 2 diabetes. Based on previous findings, FYGL, a natural hyperbranched proteoglycan extracted from the G. lucidum fruiti...

    Authors: YingXin Wang, Fanzhen Yu, Xinru Zheng, Jiaqi Li, Zeng Zhang, Qianqian Zhang, Jieying Chen, Yanming He, Hongjie Yang and Ping Zhou
    Citation: Lipids in Health and Disease 2023 22:120
  43. Lipoprotein lipase (LPL) is the key enzyme responsible for the hydrolysis of triglycerides. Loss-of-function variants in the LPL gene are associated with hypertriglyceridemia (HTG) and HTG-related diseases. Unlik...

    Authors: Yuepeng Hu, Guofu Zhang, Qi Yang, Na Pu, Kaiwei Li, Baiqiang Li, David N. Cooper, Zhihui Tong, Weiqin Li and Jian-Min Chen
    Citation: Lipids in Health and Disease 2023 22:119

Annual Journal Metrics

  • 2022 Citation Impact
    4.5 - 2-year Impact Factor
    4.9 - 5-year Impact Factor
    1.358 - SNIP (Source Normalized Impact per Paper)
    1.042 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    68 days submission to accept (Median)

    2023 Usage 
    1,810,907 downloads
    1,488 Altmetric mentions